Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Józsi M[au]:

C3 glomerulopathy - understanding a rare complement-driven renal disease. Smith RJH et al. Nat Rev Nephrol. (2019)

Factor H-related proteins determine complement-activating surfaces. Józsi M et al. Trends Immunol. (2015)

Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family. Sánchez-Corral P et al. Front Immunol. (2018)

Search results

Items: 1 to 50 of 68

1.

Functional Characterization of Secreted Aspartyl Proteases in Candida parapsilosis.

Singh DK, Németh T, Papp A, Tóth R, Lukácsi S, Heidingsfeld O, Dostal J, Vágvölgyi C, Bajtay Z, Józsi M, Gácser A.

mSphere. 2019 Aug 21;4(4). pii: e00484-19. doi: 10.1128/mSphere.00484-19.

2.

FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells.

Seguin-Devaux C, Plesseria JM, Verschueren C, Masquelier C, Iserentant G, Fullana M, Józsi M, Cohen JHM, Dervillez X.

Mol Oncol. 2019 Jul 31. doi: 10.1002/1878-0261.12554. [Epub ahead of print]

3.

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.

Trojnar E, Józsi M, Szabó Z, Réti M, Farkas P, Kelen K, Reusz GS, Szabó AJ, Garam N, Mikes B, Sinkovits G, Mező B, Csuka D, Prohászka Z.

Front Immunol. 2019 Feb 25;10:240. doi: 10.3389/fimmu.2019.00240. eCollection 2019.

4.

C3 glomerulopathy - understanding a rare complement-driven renal disease.

Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM.

Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Review.

PMID:
30692664
5.

Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.

Zwarthoff SA, Berends ETM, Mol S, Ruyken M, Aerts PC, Józsi M, de Haas CJC, Rooijakkers SHM, Gorham RD Jr.

Front Immunol. 2018 Jul 23;9:1691. doi: 10.3389/fimmu.2018.01691. eCollection 2018.

6.

Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family.

Sánchez-Corral P, Pouw RB, López-Trascasa M, Józsi M.

Front Immunol. 2018 Jul 12;9:1607. doi: 10.3389/fimmu.2018.01607. eCollection 2018. Review.

7.

Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4.

Pouw RB, Brouwer MC, van Beek AE, Józsi M, Wouters D, Kuijpers TW.

Front Immunol. 2018 Apr 17;9:729. doi: 10.3389/fimmu.2018.00729. eCollection 2018.

8.

Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H.

Fülöp T, Mészáros T, Kozma GT, Szebeni J, Józsi M.

Antibodies (Basel). 2018 Mar 14;7(1). pii: E14. doi: 10.3390/antib7010014. Review.

9.

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R.

Cserhalmi M, Uzonyi B, Merle NS, Csuka D, Meusburger E, Lhotta K, Prohászka Z, Józsi M.

Front Immunol. 2017 Dec 13;8:1800. doi: 10.3389/fimmu.2017.01800. eCollection 2017.

10.

Complement factor H family proteins in their non-canonical role as modulators of cellular functions.

Józsi M, Schneider AE, Kárpáti É, Sándor N.

Semin Cell Dev Biol. 2019 Jan;85:122-131. doi: 10.1016/j.semcdb.2017.12.018. Epub 2018 Jan 5. Review.

PMID:
29305301
11.

The Murine Factor H-Related Protein FHR-B Promotes Complement Activation.

Cserhalmi M, Csincsi ÁI, Mezei Z, Kopp A, Hebecker M, Uzonyi B, Józsi M.

Front Immunol. 2017 Sep 19;8:1145. doi: 10.3389/fimmu.2017.01145. eCollection 2017.

12.

Factor H Family Proteins in Complement Evasion of Microorganisms.

Józsi M.

Front Immunol. 2017 May 18;8:571. doi: 10.3389/fimmu.2017.00571. eCollection 2017. Review.

13.

FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.

Csincsi ÁI, Szabó Z, Bánlaki Z, Uzonyi B, Cserhalmi M, Kárpáti É, Tortajada A, Caesar JJE, Prohászka Z, Jokiranta TS, Lea SM, Rodríguez de Córdoba S, Józsi M.

J Immunol. 2017 Jul 1;199(1):292-303. doi: 10.4049/jimmunol.1600483. Epub 2017 May 22.

14.

Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome.

Trojnár E, Józsi M, Uray K, Csuka D, Szilágyi Á, Milosevic D, Stojanović VD, Spasojević B, Rusai K, Müller T, Arbeiter K, Kelen K, Szabó AJ, Reusz GS, Hyvärinen S, Jokiranta TS, Prohászka Z.

Front Immunol. 2017 Mar 30;8:302. doi: 10.3389/fimmu.2017.00302. eCollection 2017.

15.

Complement factor H modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps.

Schneider AE, Sándor N, Kárpáti É, Józsi M.

Mol Immunol. 2016 Apr;72:37-48. doi: 10.1016/j.molimm.2016.02.011. Epub 2016 Mar 1.

PMID:
26938503
16.

Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.

Schmidt CQ, Harder MJ, Nichols EM, Hebecker M, Anliker M, Höchsmann B, Simmet T, Csincsi ÁI, Uzonyi B, Pappworth IY, Ricklin D, Lambris JD, Schrezenmeier H, Józsi M, Marchbank KJ.

Immunobiology. 2016 Apr;221(4):503-11. doi: 10.1016/j.imbio.2015.12.009. Epub 2016 Jan 6.

17.

Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro.

Mészáros T, Csincsi ÁI, Uzonyi B, Hebecker M, Fülöp TG, Erdei A, Szebeni J, Józsi M.

Nanomedicine. 2016 May;12(4):1023-1031. doi: 10.1016/j.nano.2015.11.019. Epub 2015 Dec 28.

PMID:
26733258
18.

Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.

Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M.

Mol Immunol. 2016 Feb;70:47-55. doi: 10.1016/j.molimm.2015.12.005. Epub 2015 Dec 15.

PMID:
26703217
19.

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.

Veszeli N, Csuka D, Zotter Z, Imreh É, Józsi M, Benedek S, Varga L, Farkas H.

Orphanet J Rare Dis. 2015 Dec 10;10:156. doi: 10.1186/s13023-015-0374-y.

20.

Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18).

Svoboda E, Schneider AE, Sándor N, Lermann U, Staib P, Kremlitzka M, Bajtay Z, Barz D, Erdei A, Józsi M.

Immunol Lett. 2015 Nov;168(1):13-21. doi: 10.1016/j.imlet.2015.08.009. Epub 2015 Aug 22.

PMID:
26306739
21.

Factor H-related proteins determine complement-activating surfaces.

Józsi M, Tortajada A, Uzonyi B, Goicoechea de Jorge E, Rodríguez de Córdoba S.

Trends Immunol. 2015 Jun;36(6):374-84. doi: 10.1016/j.it.2015.04.008. Epub 2015 May 13. Review.

PMID:
25979655
22.

Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.

Csincsi ÁI, Kopp A, Zöldi M, Bánlaki Z, Uzonyi B, Hebecker M, Caesar JJ, Pickering MC, Daigo K, Hamakubo T, Lea SM, Goicoechea de Jorge E, Józsi M.

J Immunol. 2015 May 15;194(10):4963-73. doi: 10.4049/jimmunol.1403121. Epub 2015 Apr 8.

23.

The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.

Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.

J Biol Chem. 2015 Apr 10;290(15):9500-10. doi: 10.1074/jbc.M114.630871. Epub 2015 Feb 6.

24.

Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA.

da Silva LB, Miragaia Ldos S, Breda LC, Abe CM, Schmidt MC, Moro AM, Monaris D, Conde JN, Józsi M, Isaac L, Abreu PA, Barbosa AS.

Infect Immun. 2015 Mar;83(3):888-97. doi: 10.1128/IAI.02844-14. Epub 2014 Dec 22.

25.

Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment.

Hofer J, Giner T, Józsi M.

Semin Thromb Hemost. 2014 Jun;40(4):431-43. doi: 10.1055/s-0034-1375297. Epub 2014 May 5. Review.

PMID:
24799303
26.

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.

Józsi M, Reuter S, Nozal P, López-Trascasa M, Sánchez-Corral P, Prohászka Z, Uzonyi B.

Immunol Lett. 2014 Aug;160(2):163-71. doi: 10.1016/j.imlet.2014.01.014. Epub 2014 Feb 1. Review.

PMID:
24491679
27.

Factor H-related proteins.

Józsi M, Meri S.

Methods Mol Biol. 2014;1100:225-36. doi: 10.1007/978-1-62703-724-2_18. Review.

PMID:
24218263
28.

An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.

Hebecker M, Alba-Domínguez M, Roumenina LT, Reuter S, Hyvärinen S, Dragon-Durey MA, Jokiranta TS, Sánchez-Corral P, Józsi M.

J Immunol. 2013 Jul 15;191(2):912-21. doi: 10.4049/jimmunol.1300269. Epub 2013 Jun 14.

29.

Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils.

Svobodová E, Staib P, Losse J, Hennicke F, Barz D, Józsi M.

J Immunol. 2012 Sep 1;189(5):2502-11. doi: 10.4049/jimmunol.1200185. Epub 2012 Jul 30.

30.

Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3.

Kopp A, Strobel S, Tortajada A, Rodríguez de Córdoba S, Sánchez-Corral P, Prohászka Z, López-Trascasa M, Józsi M.

J Immunol. 2012 Aug 15;189(4):1858-67. doi: 10.4049/jimmunol.1200357. Epub 2012 Jul 11.

31.
32.

Anti-factor H antibody affecting factor H cofactor activity in a patient with dense deposit disease.

Nozal P, Strobel S, Ibernon M, López D, Sánchez-Corral P, Rodríguez de Córdoba S, Józsi M, López-Trascasa M.

Clin Kidney J. 2012 Apr;5(2):133-136. doi: 10.1093/ckj/sfs002. Epub 2012 Mar 15.

33.

Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP.

Castiblanco-Valencia MM, Fraga TR, Silva LB, Monaris D, Abreu PA, Strobel S, Józsi M, Isaac L, Barbosa AS.

J Infect Dis. 2012 Mar 15;205(6):995-1004. doi: 10.1093/infdis/jir875. Epub 2012 Jan 30.

PMID:
22291192
34.

Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.

Kopp A, Hebecker M, Svobodová E, Józsi M.

Biomolecules. 2012 Feb 7;2(1):46-75. doi: 10.3390/biom2010046.

35.

Screening for anti-factor B autoantibody in a patient with acute renal injury due to dense deposit disease.

Krmar RT, Skattum L, Bárány P, Józsi M.

Clin Nephrol. 2012 Jan;77(1):85-6. No abstract available.

36.

Human pentraxin 3 binds to the complement regulator c4b-binding protein.

Braunschweig A, Józsi M.

PLoS One. 2011;6(8):e23991. doi: 10.1371/journal.pone.0023991. Epub 2011 Aug 22.

37.

Role of pH-regulated antigen 1 of Candida albicans in the fungal recognition and antifungal response of human neutrophils.

Losse J, Svobodová E, Heyken A, Hube B, Zipfel PF, Józsi M.

Mol Immunol. 2011 Sep;48(15-16):2135-43. doi: 10.1016/j.molimm.2011.07.007. Epub 2011 Aug 4.

PMID:
21820180
38.

Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.

Strobel S, Abarrategui-Garrido C, Fariza-Requejo E, Seeberger H, Sánchez-Corral P, Józsi M.

Kidney Int. 2011 Aug;80(4):397-404. doi: 10.1038/ki.2011.152. Epub 2011 Jun 15.

39.

Anti-factor B autoantibody in dense deposit disease.

Strobel S, Zimmering M, Papp K, Prechl J, Józsi M.

Mol Immunol. 2010 Apr;47(7-8):1476-83. doi: 10.1016/j.molimm.2010.02.002. Epub 2010 Mar 1.

PMID:
20193965
40.

Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.

Hebecker M, Okemefuna AI, Perkins SJ, Mihlan M, Huber-Lang M, Józsi M.

Mol Immunol. 2010 Mar;47(6):1347-55. doi: 10.1016/j.molimm.2009.12.005. Epub 2009 Dec 29.

PMID:
20042240
41.
42.

Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H.

Mihlan M, Stippa S, Józsi M, Zipfel PF.

Cell Death Differ. 2009 Dec;16(12):1630-40. doi: 10.1038/cdd.2009.103. Epub 2009 Aug 14.

43.

Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.

Strobel S, Hoyer PF, Mache CJ, Sulyok E, Liu WS, Richter H, Oppermann M, Zipfel PF, Józsi M.

Nephrol Dial Transplant. 2010 Jan;25(1):136-44. doi: 10.1093/ndt/gfp388. Epub 2009 Aug 7.

PMID:
19666655
44.

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.

Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.

Mol Immunol. 2009 Sep;46(14):2801-7. doi: 10.1016/j.molimm.2009.05.018. Epub 2009 Jul 28. Review.

PMID:
19640589
45.

Autoantibodies in haemolytic uraemic syndrome (HUS).

Skerka C, Józsi M, Zipfel PF, Dragon-Durey MA, Fremeaux-Bacchi V.

Thromb Haemost. 2009 Feb;101(2):227-32. Review.

PMID:
19190803
46.

Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells.

Mihlan M, Hebecker M, Dahse HM, Hälbich S, Huber-Lang M, Dahse R, Zipfel PF, Józsi M.

Mol Immunol. 2009 Jan;46(3):335-44. doi: 10.1016/j.molimm.2008.10.029. Epub 2008 Dec 11.

PMID:
19084272
47.

Factor H family proteins and human diseases.

Józsi M, Zipfel PF.

Trends Immunol. 2008 Aug;29(8):380-7. doi: 10.1016/j.it.2008.04.008. Epub 2008 Jul 2. Review.

PMID:
18602340
48.

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.

Józsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C.

Blood. 2008 Feb 1;111(3):1512-4. Epub 2007 Nov 15.

PMID:
18006700
49.

Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.

Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF.

Blood. 2007 Sep 1;110(5):1516-8. Epub 2007 May 10.

PMID:
17495132
50.

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.

Zipfel PF, Edey M, Heinen S, Józsi M, Richter H, Misselwitz J, Hoppe B, Routledge D, Strain L, Hughes AE, Goodship JA, Licht C, Goodship TH, Skerka C.

PLoS Genet. 2007 Mar 16;3(3):e41. Epub 2007 Feb 1.

Supplemental Content

Support Center